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Sex steroids, including testosterone, regulate the development and function of the male skeleton.
Oury et al. (2011) identify a surprising new connection between the skeleton and the testis, which
has implications for male fertility. They show that testosterone production in the testis is directly
influenced by the bone-derived hormone osteocalcin.The sex steroids testosterone and
estrogenare essential regulators of fertility.
Acting through nuclear hormone receptors
expressed in somatic cells, testosterone
regulates the development and mainte-
nance of the male reproductive system
and, by modulating the activity of support
cells, promotes germ cell survival. Testos-
terone synthesis occurs within Leydig cells
in the testes and is regulated by luteinizing
hormone (LH) produced by the pituitary
gland. In addition to LH and follicle-stimu-
lating hormone (which is also secreted
from the pituitary), there is emerging
evidence that metabolic hormones such
as leptin (Tena-Sempere and Barreiro,
2002) and insulin (Ma and Wittert, 2010)
have impacts on testis function.
Now, Oury et al. (2011) demonstrate
that the skeleton may play a previously
unforeseen role in control of male fertility,
showing that osteocalcin (Ocn), a peptide
hormone that is secreted by bone-form-ing osteoblast cells, directly controls
testosterone production by Leydig cells
in the testis (Figure 1). Using ex vivo cell
assays, the authors demonstrate that
a factor that is secreted by osteoblasts,
but not other skeletal cell-types, markedly
increases testosterone production both
by testis explants and by isolated Leydig
cells. Speculating that this effect is likely
tobemediatedbyosteocalcin, theauthors
show that this response is lost when Ocn-
deficient osteoblasts are used but is
rescued in a dose-dependent manner by
introduction of exogenous osteocalcin.
Injection of osteocalcin also increases
serum testosterone in mice. Together,
these data strongly suggest that osteocal-
cin is indeedoneof theosteoblast-secreted
factors that are responsible for enhanced
testosterone production.
To support their in vitro data, the authors
exploit two mouse models in which osteo-
calcin function is either ablated (Ocnknockout mice) or enhanced (Esp
knockout mice, which lack an osteotestic-
ular phosphatase that negatively
regulates osteocalcin maturation).
Compared to controls, testis weight,
sperm counts, and levels of circulating
testosterone are all significantly reduced
in Ocn knockout mice and conversely
increased in Esp knockout males. Consis-
tent with these physiological changes,
Ocn-deficient males sire fewer offspring
than controls, although no significant
increase is observed using Esp-deficient
males, possibly because the availability of
oocytes acts as a limiting factor. Tissue-
specific ablation of these genes in bone
or testis confirms that osteocalcin derived
from the skeleton acts as an endocrine
factor to regulate male fertility.
How does osteocalcin influence testo-
sterone synthesis? To identify the receptor
through which osteocalcin signals, the
authors postulate that, because the
Figure 1. Hormonal Integration of the Skeleton and Testis
Testosterone (T) biosynthesis takes placewithin Leydig cells (identified here by
immunostaining for 3b-HSD, an enzyme that is involved in androgen biosyn-
thesis), located within the interstitial compartment of the testis. Testosterone
also acts as a pro-hormone for biosynthesis of estrogens (E); both hormones
have been implicated in regulation of bone turnover. Leydig cells express G
protein-coupled receptors (GPCRs) that bind the endocrine hormones lutei-
nizing hormone (Lhcgr) and osteocalcin (Gprc6a). Luteinizing hormone (LH) is
synthesized and secreted by the pituitary gland and the latter produced by
bone osteoblasts. Stimulation of both GPCRs results in increased concen-
trations of intracellular cAMP and increased expression of key regulators of the
steroidogenic pathway. Secretion of LH is subject to negative feedback
regulation by testosterone and estrogens. Testosterone, acting via androgen
receptors expressed in somatic cells, but not germ cells, plays a critical role in
the regulation of male fertility.hormone stimulates cyclic
adenosine monophosphate
(cAMP) production in Leydig
cells, it is most likely a
G protein-coupled receptor
(GPCR). By performing a
comprehensive analysis of
the expression pattern of 103
GPCRs, they identify four that
are enriched in Leydig cells.
Notably, a previous study re-
ported that deletion of one of
these, Gprc6a, results in
a testicular phenotype, with
increased circulating levels of
estradiol and reduced levels
of testosterone (Pi et al.,
2008). Oury and colleagues
now demonstrate that Leydig
cell-specific impairment of
Gprc6a expression generates
mice with an identical pheno-
type to Ocn-deficient animals.
Their experiments suggest
that osteocalcin signals
through Gprc6a to regulate
cAMP and the transcription
factor CREB, which in turn
promotes the expression of
key steroidogenic enzymes.
One outstanding question
that remains to be addressed
is the relationship between
LH- and osteocalcin-depen-
dent signaling in regulation of
Leydig cell function. Both of
these hormones exert endo-crine control over testosterone production,
and although they act through different
GPCRs, both are coupled to activation of
cAMP-dependent signaling cascades. In
this study however, even though animals
lacking Ocn have significantly increased
levels of serum LH, the increase in LH is
apparently insufficient to compensate for
lossof function of the osteocalcin pathway.
This suggests that LH and osteocalcinmay
act through different effector molecules. It
would therefore be interesting to establish
whether exogenous osteocalcin could
rescue the phenotype of LH-beta knockout
mice (Zhang et al., 2001).Androgens such as testosterone not
only regulate testis function, but also
play a key role in the function of the rest
of the male urogenital system. Oury et al.
show that mice in which Leydig cell func-
tion is not stimulated by osteocalcin, due
to the absence of either the ligand or its
receptor, have significantly smaller
epididymides and seminal vesicles. Ocn-
deficient males also have significantly
increased levels of serum estradiol,
leading to a disturbance in the testostero-
ne:estradiol (T:E) ratio. Estrogens are
known to regulate both male fertility and
prostate function, and age-dependentCell 144, March 4changes in the T:E ratio have
been implicated in the devel-
opment of benign and malig-
nant prostate disease. Inter-
estingly, a recent paper has
identified GPRC6A as
a susceptibility locus for pros-
tate cancer (Takata et al.,
2010). Disturbances in func-
tional activity of bone cells
associated with aging may
therefore have ramifications
not only for male fertility, but
also for susceptibility to pros-
tate cancer.
The identification of osteo-
calcin as a regulator of male
fertility represents a step
change in our understanding
of the homeostatic mecha-
nisms that are responsible
for regulation of androgen
biosynthesis in the testis. G
protein-coupled receptors
such as Gprc6A are popular
targets for drug development,
and these studies may there-
fore pave the way for treat-
ments for male infertility or
other hormone-dependent
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